Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Effects of a Clinical Dietary Intervention During Inpatient Treatment (FASTA)

10 mai 2021 mis à jour par: Andreas Michalsen, Charite University, Berlin, Germany

Effects of a Clinical Dietary Intervention During Inpatient Treatment (Modified Fasting in Metabolic Syndrome, Osteoarthritis of the Hip or Knee, Rheumatoid Arthritis and Fibromyalgia)

The purpose of the study is a scientific and prospective documentation of the clinical effects of an inpatient treatment at the Immanuel Hospital of Berlin, in the department for complementary and integrative medicine, with the use of a modified fasting regime. A pre- and post- as well as group comparisons are planned. Patients that are admitted to the inpatient department for metabolic syndrome, osteoarthritis of the hip or knee, rheumatoid arthritis and fibromyalgia will be enrolled in the study.

Aperçu de l'étude

Statut

Actif, ne recrute pas

Les conditions

Intervention / Traitement

Autre: Prolonged modified fasting

Description détaillée

At the beginning, during and at the end of the treatment at the inpatient department routine blood parameters, anthropometric parameters and certain scores and parameters specific to the different conditions will be measured. Questionnaires will be filled out by patients before and after the treatment as well as 3, 6 and 12 months after leaving the inpatient department.

Type d'étude

Observationnel

Inscription (Anticipé)

500

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

Allemagne
- Berlin
  - Berlin-Wannsee, Berlin, Allemagne, 14109
    - Immanuel Hospital

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

18 ans à 85 ans (Adulte, Adulte plus âgé)

Accepte les volontaires sains

Non

Sexes éligibles pour l'étude

Tout

Méthode d'échantillonnage

Échantillon de probabilité

Population étudiée

Regular hospitalised patients

La description

Inclusion Criteria:

The patient is consents to participating in the trial during the first 24h of his or her stay in the inpatient naturopathic department of the Immanuel Hospital.
Written informed consent is given
The referral diagnosis is one of the following: diabetes mellitus type 2/metabolic syndrome, osteoarthritis of the hip, osteoarthritis of the knee, rheumatoid arthritis, fibromyalgia.

Exclusion Criteria:

Language barries to understanding the instructions of the study personnel
Dementia or other strong cognitive impairment
Pregnant or lactating women
Taking part in another study at the same time

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats	Description de la mesure	Délai
Fibromyalgia Impact Questionnaire (FIQ) Délai: Change Baseline, 2 weeks, 3 months, 6 months, 12 months	Questionnaire; The FIQ is scored in such a way that a higher score indicates a greater impact of the syndrome on the person. Each of the 10 items has a maximum possible score of 10. Thus the maximum possible score is 100. The average FM patient scores about 50, severely afflicted patients are usually 70 plus.	Change Baseline, 2 weeks, 3 months, 6 months, 12 months
Disease Activity Score 28 (DAS 28) Délai: Change Baseline, 2 weeks, 3 months, 6 months, 12 months	Questionnaire with Clinical Examination; Change from Baseline in the DAS-28, range from 2.0 to 10.0 while higher values meaning a higher disease activity and below of 2.6 meaning remission	Change Baseline, 2 weeks, 3 months, 6 months, 12 months
Health Assessment Questionnaire (HAQ) Délai: Change Baseline, 2 weeks, 3 months, 6 months, 12 months	Questionnaire; Change from Baseline in the HAQ, range from 0 to 3 while higher values meaning a higher grade of disability	Change Baseline, 2 weeks, 3 months, 6 months, 12 months
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Délai: Change Baseline, 2 weeks, 3 months, 6 months, 12 months	Questionnaire consisting of 24 items divided into 3 subscales: Pain (5items), Stiffness (2 items), Physical Function (17 items). The test questions are scored on a scale of 0-4, which correspond to: None (0), Mild (1), Moderate (2), Severe (3), and Extreme (4). The scores for each subscale are summed up, with a possible score range of 0-20 for Pain, 0-8 for Stiffness, and 0-68 for Physical Function. Higher values meaning a higher grade of disability.	Change Baseline, 2 weeks, 3 months, 6 months, 12 months
Summary of Diabetes Self Care Activities Measure (SDSCA) Délai: Change Baseline, 2 weeks, 3 months, 6 months, 12 months	Questionnaire; 11 items with each item scored on a scale of 0-7.	Change Baseline, 2 weeks, 3 months, 6 months, 12 months

Mesures de résultats secondaires

Mesure des résultats	Description de la mesure	Délai
Pain on Visual Analogue Scale (VAS) Délai: Change Baseline, 2 weeks, 3 months, 6 months, 12 months	Questionnaire	Change Baseline, 2 weeks, 3 months, 6 months, 12 months
Hospital Anxiety and Depression Scale (HADS) Délai: Change Baseline, 2 weeks, 3 months, 6 months, 12 months	Questionnaire; HADS: Assessing full scale, range 0-42, lower score meaning a better outcome	Change Baseline, 2 weeks, 3 months, 6 months, 12 months
Perceived Stress Scale (PSS) Délai: Change Baseline, 2 weeks, 3 months, 6 months, 12 months	Questionnaire; Change from Baseline in the PSS, range from 0 to 4 in each item. Scores are obtained by reversing responses (e.g., 0 = 4, 1 = 3, 2 = 2, 3 = 1 & 4 = 0) to the positively stated items and then summing across all scale items while higher values meaning a higher grade of perceived stress.	Change Baseline, 2 weeks, 3 months, 6 months, 12 months
Quality of Life (WHO-5) Délai: Change Baseline, 2 weeks, 3 months, 6 months, 12 months	Questionnaire; Change from Baseline in the WHO-5, range from 0 to 100 % while higher values meaning a higher grade of well-being	Change Baseline, 2 weeks, 3 months, 6 months, 12 months
Body-Mass-Index (BMI) Délai: Change Baseline, 2 weeks	Anthropometry	Change Baseline, 2 weeks
Blood pressure Délai: Change Baseline, 2 weeks	Measuring systolic and diastolic blood pressure in mmHg	Change Baseline, 2 weeks
24h-Blood pressure Délai: Change Baseline, 2 weeks	Measuring systolic and diastolic blood pressure with Device "Mobil-O-Graph"	Change Baseline, 2 weeks
Blood count Délai: Change Baseline, 2 weeks	Laboratory test	Change Baseline, 2 weeks
Glomerular filtration rate (GFR) Délai: Change Baseline, 2 weeks	Laboratory test	Change Baseline, 2 weeks
Blood lipids Délai: Change Baseline, 2 weeks	triglycerides (mmol/L), total cholesterol (mmol/L), LDL (mmol/L), HDL (mmol/L), fasting glucose (mmol/L)	Change Baseline, 2 weeks
CRP Délai: Change Baseline, 2 weeks	CRP in milligram per liter (mg/L)	Change Baseline, 2 weeks
Liver enzymes (GOT, GPT) Délai: Change Baseline, 2 weeks	Hepatic transaminases (GPT, GOT in U/L)	Change Baseline, 2 weeks
Stepcounter Délai: Change Baseline, 2 weeks	With Device "Everion"	Change Baseline, 2 weeks
Heart Rate Variability Délai: Change Baseline, 2 weeks	With Device "Faros 180"	Change Baseline, 2 weeks
Heart Rate Délai: Change Baseline, 2 weeks	With Device "Everion"	Change Baseline, 2 weeks
Blood Oxygenation Délai: Change Baseline, 2 weeks	With Device "Everion"	Change Baseline, 2 weeks

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Parrainer

Charite University, Berlin, Germany

Les enquêteurs

Chercheur principal: Andreas Michalsen, Prof. Dr., study principal investigator

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

1 février 2018

Achèvement primaire (Anticipé)

1 mars 2022

Achèvement de l'étude (Anticipé)

1 mars 2022

Dates d'inscription aux études

Première soumission

20 décembre 2018

Première soumission répondant aux critères de contrôle qualité